Simponi®

INN: golimumab

Approved for use in:

Ulcerative Colitis (moderate-severe)

Type/Class

Originator Biologic

Delivery Route

Subcutaneous Injection

Health Canada Approval

2009

Storage

Refrigerate in original package between 2 and 8°C, do not freeze, and do not shake before use; protect from light until time of use, can be kept at room temperature for maximum of 30 days, do not return to refrigerator once removed.

Use in Older Adults (65+)

May be used, please consult your doctor.

Pregnancy Indication

Infants may be at increased risk for infection.

Breastfeeding Indication

Not recommended due to potential for adverse reactions in nursing infants.

Pediatric Indication

Safety and efficacy not established.

Learn More

View the Simponi® product monograph.